Business Segments Bright Minds Biosciences Inc.
Equities
DRUG
CA10919W4056
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.39 CAD | 0.00% |
|
-10.67% | +2.68% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Biological Products | |||||||
Total Assets | 20.04M | 12.09M | 6.88M | 6.1M | 84.42M | ||
Interest Expense | - | - | - | -8.94K | -35.85K | ||
EBT | -8.65M | -14.96M | -7.37M | -2.8M | -12.23M | ||
D&A | - | 6.04K | 72.45K | 73.36K | 76.87K | ||
Net Income | -8.65M | -14.96M | -7.37M | -2.8M | -12.23M |
Geographical Revenue Distribution History
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Total Assets | 20.04M | 12.09M | 6.88M | 6.1M | 84.42M | ||
Interest Expense | - | - | - | -8.94K | -35.85K | ||
D&A | - | 6.04K | 72.45K | 73.36K | 76.87K | ||
Net Income | -8.65M | -14.96M | -7.37M | -2.8M | -12.23M | ||
EBT | -8.65M | -14.96M | -7.37M | -2.8M | -12.23M |
- Stock Market
- Equities
- DRUG Stock
- Financials Bright Minds Biosciences Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition